Search results for " arthritis"

showing 10 items of 629 documents

JUVENILE IDIOPATHIC ARTHRITIS AND FITNESS: A TEAMWORK

2018

Introduction: Patients with Juvenile Idiopathic Arthritis (JIA) have limited fitness and reduced aerobic and anaerobic exercise capacity vs. healthy peers. Furthermore, low intensity exercise programs are safe in children with JIA and may improve fitness, joint excursion and quality of life, reduce pain, fatigue and the employ to antiinflammatory drugs. Objectives: The purpose of the study was to evaluate postural and balance deficits and fitness with specific test battery in children and adolescents affected by JIA. Methods: We enrolled 30 patients with JIA (13 M; 17 F; age: 8-18 years); among those, 7 were evaluated longitudinally in the period 2016-2018, comparing the tests in different …

Settore MED/38 - Pediatria Generale E SpecialisticaJUVENILE IDIOPATHIC ARTHRITIS FITNESS
researchProduct

Canakinumab in systemic juvenile idiopathic arthritis: clinical inactive disease rate and safety in italian patients

2019

Introduction: Systemic juvenile idiopathic arthritis (sJIA) is a polygenic autoinflammatory disease. The pathophysiology is still unclear, it is now well known that innate immune mechanisms play a central role with overproduction of inflammatory cytokines. The increased knowledge on the role of these cytokines has provided a change in the natural history of the disease with the introduction of the targeted treatments. Remarkable results has been observed with canakinumab, an anti-interleukin-1β monoclonal antibody, in two clinical trials but little information are available in real life. Objectives: To evaluate clinical inactive disease rate and safety of canakinumab in Italian patients wit…

Settore MED/38 - Pediatria Generale E SpecialisticaSystemic juvenile idiopathic arthritis canakinumab IL1Canakinumab Systemic Juvenile Idiopathic Arthritis Interleukin-1β
researchProduct

Intra- and Juxta-Articular Osteoid Osteoma Mimicking Arthritis: Case Series and Literature Review

2023

Background: Intra- and juxta-articular osteoid osteomas are rare, representing less than 10% of all osteomas. Compared to the classic diaphyseal or metaphyseal site of long bones, they often have an atypical onset, a longest diagnostic delay, and frequent initial misdiagnoses, with pictures that can mimic inflammatory monoarthritis. We aimed to describe a case series, and to provide a literature review of this uncommon and misleading tumor location. Methods: We performed a retrospective analysis of patients referred to three pediatric rheumatology centers, with a final diagnosis of articular osteoid osteoma. A review of the literature was additionally conducted. Results: We included 10 pati…

Settore MED/38 - Pediatria Generale E Specialisticaarthritis bone tumor child diagnosis imaging joint pain juvenile idiopathic arthritis osteoid osteoma. rheumatic diseases synovitisPediatrics Perinatology and Child Healthosteoid osteoma; arthritis; child; joint pain; synovitis; juvenile idiopathic arthritis; rheumatic diseases; bone tumor; imaging; diagnosisChildren
researchProduct

Disease activity states, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etan…

2017

The advent of biologic medications has increased considerably the potential for treatment benefit in juvenile idiopathic arthritis (JIA), with clinical remission being now achievable in a substantial proportion of patients. However, there is a need of data from the real world of clinical practice to evaluate thoroughly the efficacy and safety profile of the biologic agents currently approved.

Settore MED/38 - Pediatria Generale E Specialisticabiologic medications etanerceptjuvenile idiopathic arthritis
researchProduct

Hypocomplementemia in children with juvenile idiopatic arthritis treated with tocilizumab: personal records

2017

The relieve of a reduction in complement levels was recently reported in adults with Rheumatoid Arthritis treated with tocilizumab (TCZ). However, there are no data in children with Juvenile Idiopathic Arthritis (JIA) treated with TCZ.

Settore MED/38 - Pediatria Generale E Specialisticatocilizumab Rheumatoid Arthritis Juvenile Idiopathic Arthritis
researchProduct

Impaired Trunk Posture in Women With Fibromyalgia

2018

A cross-sectional study.The main goal of the study was to analyze posture of Fibromyalgia syndrome (FMS) in women compared with healthy subjects to establish if posture assessment could be useful to characterize the syndrome. Secondarily, we explored the impact of sedentary behavior on trunk posture.Pain has been associated with poor static postures, however there is little information on the effect of FMS, which is characterized by widespread pain, on trunk posture.One hundred eighteen women with FMS and 110 healthy counterparts participated in this study, in which trunk posture was assessed. The thoracic kyphosis, forward head position, and shoulder position (basal and maximum protraction…

Shouldermedicine.medical_specialtyFibromyalgiaCross-sectional studyPostureMEDLINE03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationFibromyalgiaHumansMedicineOrthopedics and Sports MedicineKyphosisTrunk postureAged030203 arthritis & rheumatologybusiness.industryHealthy subjectsTorsoMiddle Agedmedicine.diseaseCross-Sectional StudiesFibromyalgia syndromeFemaleNeurology (clinical)business030217 neurology & neurosurgerySpine
researchProduct

Psoriatic arthritis and COVID ‐19 pandemic: Consequences in medical treatment?

2020

The COVID‐19 pandemic has a strong negative impact on human society world‐wide. Patients with immune‐mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID‐19 the following problems are addressed: (a) Can systemic treatment reduce comorbidities of PsA that are also comorbidities for COVID‐19? Does systemic medical treatment pose an increased risk of infection with SARS‐CoV‐2? Does systemic drug therapy have an impact on the risk of pulmonary fibrosis ‐ a factor with strong negativ…

Special Issue Articlesmedicine.medical_specialtyDiseaseComorbidityDermatologyPlacebo030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritisPsoriatic arthritis; systemic medical treatment0302 clinical medicinePharmacotherapyCOVID‐19Internal medicinePandemicmedicineHumansJanus Kinase InhibitorsbiologicsBiological Productsbusiness.industrySARS-CoV-2Tumor Necrosis Factor-alphaArthritis PsoriaticInterleukinSpecial Issue ArticleCOVID-19General Medicinemedicine.diseaseComorbiditysmall molecules030220 oncology & carcinogenesisAirwaybusinessDermatologic Therapy
researchProduct

Isolated osteoblastoma of the cuboid bone: A case report and review of the literature

2020

Osteoblastoma is a relatively rare, benign, bone-forming tumor, commonly observed in the second and third decades of life. Spine and the long tubular bones are the most common sites of involvement. Osteoblastoma is infrequently seen in other sites, including the bones of hand and foot. A rare case of a 35-year-old man that presented an osteoblastoma of the cuboid bone is reported. The patient was treated with surgical resection and grafting. After the intervention, the patient recovered with no clinical and radiological evidence of recurrence after one year of follow-up. Several cases of osteoblastoma-like variant of osteosarcoma of the cuboid have been previously reported, but, to our know…

Surgical resectionAdultMalemedicine.medical_specialtyPainBone Neoplasms03 medical and health sciencesBone-formin0302 clinical medicineOsteoblastomaCuboid boneRare caseBone tumorsPathologyMedicineHumansOrthopedics and Sports MedicineOsteoblastomaPodiatryMidfootBone tumor030203 arthritis & rheumatologyCuboidBone tumors; Bone-forming; Midfoot; Pain; Pathology; Rare disease.business.industry030229 sport sciencesTarsal Bonesmedicine.diseaseMidfoot PathologyBone-formingOsteosarcomaBone formingRadiologybusinessRare diseaseRare disease
researchProduct

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academ…

2016

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed specifically for patients with this disease entity, and topical and systemic drugs are mostly used 'off-label'. The aim of the present guideline was to achieve a broad consensus on treatment strategies for patients with CLE by a European subcommittee, guided by the European Dermatology Forum (EDF) and supported by the European Academy of Dermatology and Venereology (EADV). In total, 16 European participants were included in this project and agreed on all recommendations. Topical corticosteroids remain the mainstay of trea…

Systemic diseasemedicine.medical_specialtyVenereologyConsensusCalcineurin InhibitorsDermatologyDapsone030207 dermatology & venereal diseases03 medical and health sciencesAntimalarialsRetinoids0302 clinical medicineAdrenal Cortex HormonesmedicineLupus Erythematosus CutaneousHumans610 Medicine & healthlupus erythematous cuteneous guidelines treatmentLenalidomideLenalidomide030203 arthritis & rheumatologyBiological ProductsLupus erythematosusbusiness.industryfungiGuidelineMycophenolic Acidmedicine.diseaseDermatologyThalidomideClinical trialThalidomideInfectious DiseasesMethotrexatePractice Guidelines as TopicbusinessDapsoneImmunosuppressive Agentsmedicine.drug
researchProduct

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

2021

Ankylosing spondylitis (AS) is a chronic inflammatory disease with hallmarks of both autoimmune and autoinflammatory pathology. In this Review, the authors examine the evidence for both disease processes and aim to reconcile the two.Ankylosing spondylitis (AS) is a chronic inflammatory disorder of unknown aetiology. Unlike other systemic autoimmune diseases, in AS, the innate immune system has a dominant role characterized by aberrant activity of innate and innate-like immune cells, including gamma delta T cells, group 3 innate lymphoid cells, neutrophils, mucosal-associated invariant T cells and mast cells, at sites predisposed to the disease. The intestine is involved in disease manifesta…

T cellInflammationmedicine.disease_causeAutoimmune DiseaseAutoimmunityAutoimmune Diseases03 medical and health sciences0302 clinical medicineImmune systemRheumatologyMedicineAnimalsHumansSpondylitis Ankylosing030203 arthritis & rheumatologyInnate immune systembiologybusiness.industryAnimalInnate lymphoid cellHereditary Autoinflammatory DiseasesAutoantibodyHereditary Autoinflammatory Diseasemedicine.anatomical_structureImmunologybiology.proteinAntibodymedicine.symptombusiness030215 immunologyHuman
researchProduct